Boehringer Ingelheim Investments

Boehringer Ingelheim has invested in 12 companies and its latest investment was Ilara Health on Feb 11, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Ilara Health is a Kenya-based company that provides services such as diagnostic device financing, franchise programs and pharmaceutical supplies for urban and rural clinics.
$4.2M
Feb 11, 2024
-
Otto is a Texas-based customer engagement platform that provides solutions such as practice management, appointment scheduling and payment processing for veterinarians.
$43M
Aug 30, 2023
-
Otto is a Texas-based customer engagement platform that provides solutions such as practice management, appointment scheduling and payment processing for veterinarians.
$32.5M
May 07, 2023
-
Otto is a Texas-based customer engagement platform that provides solutions such as practice management, appointment scheduling and payment processing for veterinarians.
-
Mar 03, 2022
-
Metabomed is a biotechnology company that discovers, develops and commercializes small molecule drugs for the treatment of cancer.
$12.5M
Dec 18, 2019
-

Frequently Asked Questions about Boehringer Ingelheim

  1. What is Boehringer Ingelheim investing in?

    Boehringer Ingelheim has invested in 12 companies including Ilara Health, Otto and Otto
  2. What company did Boehringer Ingelheim invest in?

    Boehringer Ingelheim invested in a total 12 companies including Ilara Health, Otto and Otto
  1. What are the top 5 investments by Boehringer Ingelheim?

    The top companies in which Boehringer Ingelheim invested are Ilara Health, Otto, Otto, Otto and Metabomed